Neuland Laboratories Limited (NEULANDLAB) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE794A01010
Key metrics
- Market Cap
- ₹29,541 Cr
- P/E Ratio
- 59.42
- EPS
- 388.87
- Book Value
- 1,461.02
- P/B Ratio
- 15.75
- ROE
- 19.42%
- ROCE
- 22.52%
- Debt / Equity
- 0.16
- Net Margin
- 18.84%
- Revenue Growth
- 34.7%
- Profit Growth
- 39.94%
- Dividend Yield
- 0.15%
- 52W High
- ₹23,881.00
- 52W Low
- ₹11,500.00
- Market Cap Band
- large cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Neuland Laboratories Limited
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Employees
- 2,183
- Promoter Holding
- 37.74%
The full Neuland Laboratories Limited analysis
Create a free account to open the complete NEULANDLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.